Product

Avonex

Aliases

BG9418, interferon beta-1a, Interferon-beta-alpha1

3 clinical trials

2 indications

Indication

Multiple Sclerosis

Indication

Relapsing-Remitting

Clinical trial

Vumerity (Diroximel Fumarate) Prospective MS Pregnancy Exposure Registry

Status: Recruiting, Estimated PCD: 2032-07-06

Clinical trial

Phase II, Multicenter, Randomized, Parallel-Group, Partially Blinded, Placebo and Avonex Controlled Dose Finding Study to Evaluate the Efficacy As Measured by Brain MRI Lesions, and Safety of 2 Dose Regimens of Ocrelizumab in Patients With RRMS

Status: Completed, Estimated PCD: 2012-03-09

Clinical trial

INFORM - Interferon-Beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-Based Drug Utilisation Study in Finland and Sweden

Status: Not yet recruiting, Estimated PCD: 2026-03-31